SOURCE: Stock Market Alerts

August 26, 2009 08:38 ET

Stocks this Morning: Dragon Capital Group - August 26, 2009

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC.

MIAMI, FL--(Marketwire - August 26, 2009) - Stock Market Alert's performance stock list includes: Dragon Capital Group Corp (PINKSHEETS: DRGV), Human Genome Sciences Inc (NASDAQ: HGSI), Matrixx Initiatives, Inc. (NASDAQ: MTXX) and Gilead Sciences, Inc. (NASDAQ: GILD).

Breaking News: Market Advisors, Inc. issues "Initiating Coverage" Report on Dragon Capital Group (PINKSHEETS: DRGV) with a speculative buy and a price objective of $0.047 per Share. The company, a leading holding company of emerging high-tech companies in China, issued a press release early this morning announcing that a new research report has been issued regarding Dragon Capital Group Corporation by Market Advisors, Inc. "Fundamental Analysis for Today's Investments" with a "Speculative Buy" and a $0.047 intermediate price objective.

To view the report, please visit a leading holding company of emerging high-tech companies in China.

Last week, the company reported announced its financial results for the second quarter ended June 30, 2009. Financial highlights included:

Revenue for the second quarter ended June 30, 2009 was $15.0 million, a 27% increase over the $11.8 million recorded in the second quarter of 2008. Cost of goods sold for the second quarter of 2009 were $14.1 million compared to $11.2 million in the second quarter of 2008. Net income from continuing operations for the second quarter of 2009 was $124,500, increasing from the $31,000 recorded in the first quarter of 2009. Net income in the second quarter of 2008 was approximately $215,000. This decrease in net income was largely attributable to an increase in selling expenses as a result of the challenging economic environment.

Revenue for the first six months of 2009 reached $26.9 million, increasing by 20% from the $22.3 million recorded in the first six months of 2008. For the first six months of 2009, net income from continuing operations was $155,400 down from $450,800 in the first six months of 2008 and mainly attributed to higher selling expenses in 2009.

At June 30, 2009, total assets were $14.6 million compared to $15.9 million at December 31, 2008. At June 30, 2009, shareholder equity was $7.1 million and total current assets were $14.3 million with working capital of approximately $7.8 million.

The stock closed yesterday at under a Penny a share.

For an in-depth profile of Dragon Capital Group, visit

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

*** This free service can be discontinued at any time by replying to any one of the alerts with the word "stop"

Human Genome Sciences Inc (NASDAQ: HGSI) up 11.7% on 23.5 million shares traded. Human Genome Sciences is a commercially focused biopharmaceutical company. In the first half of 2009, HGS achieved its first product revenues of $162.7 million when we delivered raxibacumab (ABthrax™) to the U.S. Strategic National Stockpile for the treatment of inhalation anthrax. HGS has two other products in late-stage clinical development: ZALBIN™ (formerly Albuferon(®)) for chronic hepatitis C and BENLYSTA™ (formerly LymphoStat-B(®)) for systemic lupus erythematosus.

Matrixx Initiatives, Inc. (NASDAQ: MTXX) up 22.3% on 8.5 million shares traded. Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems.

Gilead Sciences, Inc. (NASDAQ: GILD) up 0.5% on 5.7 million shares traded. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

This advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company also maintains a contractual, working relationship with Wall Street Capital Funding LLC. and its Wall Street News Alert brand. For current services performed for Dragon Capital Group Corp (PINKSHEETS: DRGV), China Direct Industries, Inc. ("China Direct Industries"), Sunwin International Neutraceuticals, Inc., China America Holdings and China Armco Metals, Inc., the company has been compensated a total of Fifty Thousand Dollars by China Direct Investments Inc., a Florida corporation, and a wholly owned subsidiary of China Direct. The company does not hold any shares of the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.